BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan YS, He Q, Wang MQ. Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol. 2012;2012:480650. [PMID: 22966466 DOI: 10.5402/2012/480650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Ni JY, Xu LF, Wang WD, Sun HL, Chen YT. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(45): 17206-17217 [PMID: 25493037 DOI: 10.3748/wjg.v20.i45.17206] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
2 Vogl TJ, Lahrsow M. The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases. Cancers (Basel) 2022;14:1503. [PMID: 35326651 DOI: 10.3390/cancers14061503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun Y, Bai H, Xia W, Wang D, Zhou B, Zhao X, Yang G, Xu L, Zhang W, Liu P, Xu J, Meng S, Liu R, Gao X. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI. J Magn Reson Imaging 2020;52:1083-90. [PMID: 32233054 DOI: 10.1002/jmri.27143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Mariappan P, Weir P, Flanagan R, Voglreiter P, Alhonnoro T, Pollari M, Moche M, Busse H, Futterer J, Portugaller HR, Sequeiros RB, Kolesnik M. GPU-based RFA simulation for minimally invasive cancer treatment of liver tumours. Int J Comput Assist Radiol Surg 2017;12:59-68. [PMID: 27538836 DOI: 10.1007/s11548-016-1469-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
5 Tian L, Lu L, Feng J, Melancon MP. Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization procedures. Acta Pharm Sin B 2018;8:360-70. [PMID: 29881675 DOI: 10.1016/j.apsb.2018.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
6 Sommer CM, Do TD, Schlett CL, Flechsig P, Gockner TL, Kuthning A, Vollherbst DF, Pereira PL, Kauczor HU, Macher-göppinger S. In vivo characterization of a new type of biodegradable starch microsphere for transarterial embolization. J Biomater Appl 2017;32:932-44. [DOI: 10.1177/0885328217746674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
7 Ahmed S, de Souza NN, Qiao W, Kasai M, Keem LJ, Shelat VG. Quality of life in HCC Patients Treated with Transarterial Chemoembolization. HPB Surg. 2016;2016:6120143. [PMID: 27143815 DOI: 10.1155/2016/6120143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
8 Wu Y, Wang L, Zhang K, Zhou L, Zhang X, Jiang X, Zhu C. N-Butyl-2-cyanoacrylate-based injectable and in situ-forming implants for efficient intratumoral chemotherapy. Drug Deliv 2017;24:729-36. [PMID: 28440691 DOI: 10.1080/10717544.2017.1309478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Qu K, Yan Z, Wu Y, Chen Y, Qu P, Xu X, Yuan P, Huang X, Xing J, Zhang H, Liu C, Zhang J. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma: Chemoembolization aggravated fibrosis. J Gastroenterol Hepatol 2015;30:925-32. [DOI: 10.1111/jgh.12873] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
10 Chen P, Duan X, Li X, Li J, Ba Q, Wang H. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α. Oncogene 2020;39:2863-76. [PMID: 32034309 DOI: 10.1038/s41388-020-1190-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Tseeleesuren D, Hsiao H, Kant R, Huang Y, Tu H, Lai C, Huang S, Yen C. The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma. Medicina 2022;58:212. [DOI: 10.3390/medicina58020212] [Reference Citation Analysis]
12 Scoville SD, Cloyd JM, Pawlik TM. Treatment of neuroendocrine liver metastases: a patent landscape review. Pharm Pat Anal 2020;9:29-32. [PMID: 32406324 DOI: 10.4155/ppa-2020-0009] [Reference Citation Analysis]
13 Chen J, White SB, Harris KR, Li W, Yap JW, Kim DH, Lewandowski RJ, Shea LD, Larson AC. Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model. Biomaterials 2015;61:299-306. [PMID: 26022791 DOI: 10.1016/j.biomaterials.2015.05.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
14 Li L, Liu Y, Li H, Guo X, He X, Geng S, Zhao H, Peng X, Shi D, Xiong B, Zhou G, Zhao Y, Zheng C, Yang X. Rational design of temperature-sensitive blood-vessel-embolic nanogels for improving hypoxic tumor microenvironment after transcatheter arterial embolization. Theranostics 2018;8:6291-306. [PMID: 30613298 DOI: 10.7150/thno.28845] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
15 Hu J, Wu W, Qin Y, Liu C, Wei P, Hu J, Seeberger PH, Yin J. Fabrication of Glyco‐Metal‐Organic Frameworks for Targeted Interventional Photodynamic/Chemotherapy for Hepatocellular Carcinoma through Percutaneous Transperitoneal Puncture. Adv Funct Mater 2020;30:1910084. [DOI: 10.1002/adfm.201910084] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
16 Dong G, Lin XH, Liu HH, Gao DM, Cui JF, Ren ZG, Chen RX. Intermittent hypoxia alleviates increased VEGF and pro-angiogenic potential in liver cancer cells. Oncol Lett 2019;18:1831-9. [PMID: 31423251 DOI: 10.3892/ol.2019.10486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
17 Zhang L, Wang B, Cao P, Zhang Q, Liu X, Li M. Combination therapy with percutaneous osteoplasty and transcatheter arterial chemoembolization for the treatment of pelvic bone metastases: preliminary report. Support Care Cancer 2021;29:2529-36. [PMID: 32945958 DOI: 10.1007/s00520-020-05783-5] [Reference Citation Analysis]
18 Currie BM, Soulen MC. Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE. Semin Intervent Radiol 2017;34:92-100. [PMID: 28579676 DOI: 10.1055/s-0037-1602591] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
19 Shao W, Zhang F, Cong N, Li J, Song J. Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma. Oncol Lett 2014;8:2263-6. [PMID: 25289106 DOI: 10.3892/ol.2014.2512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
20 Zhou L, Zhang LZ, Wang JY, Li YW, Hu HD, Peng XM, Zhao Y, Wang XM, Xie H, Liu CZ, Wang HM. Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia. Mol Clin Oncol 2017;7:435-42. [PMID: 28811901 DOI: 10.3892/mco.2017.1345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
21 Pinato DJ, Howell J, Ramaswami R, Sharma R. Review article: delivering precision oncology in intermediate-stage liver cancer. Aliment Pharmacol Ther 2017;45:1514-23. [DOI: 10.1111/apt.14066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
22 Xie H, Wang H, An W, Ma W, Qi R, Yang B, Liu C, Gao Y, Xu B, Wang W. The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients. PLoS One. 2014;9:e89081. [PMID: 24586515 DOI: 10.1371/journal.pone.0089081] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
23 Zane KE, Makary MS. Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers (Basel) 2021;13:5430. [PMID: 34771593 DOI: 10.3390/cancers13215430] [Reference Citation Analysis]
24 Ye Z, Wu W, Qin Y, Hu J, Liu C, Seeberger PH, Yin J. An Integrated Therapeutic Delivery System for Enhanced Treatment of Hepatocellular Carcinoma. Adv Funct Mater 2018;28:1706600. [DOI: 10.1002/adfm.201706600] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
25 Jeon SI, Kim MS, Kim HJ, Kim YI, Jae HJ, Ahn CH. Biodegradable poly(lactide-co-glycolide) microspheres encapsulating hydrophobic contrast agents for transarterial chemoembolization. J Biomater Sci Polym Ed 2021;:1-17. [PMID: 34613885 DOI: 10.1080/09205063.2021.1990472] [Reference Citation Analysis]
26 Gao Y, Lyu L, Feng Y, Li F, Hu Y. A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents. Int J Med Sci 2021;18:3066-81. [PMID: 34400877 DOI: 10.7150/ijms.59930] [Reference Citation Analysis]
27 Anteby R, Kemeny NE, Kingham TP, D'Angelica MI, Wei AC, Balachandran VP, Drebin JA, Brennan MF, Blumgart LH, Jarnagin WR. Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy. J Am Coll Surg 2021;232:332-8. [PMID: 33387624 DOI: 10.1016/j.jamcollsurg.2020.11.013] [Reference Citation Analysis]
28 Negussie AH, de Ruiter QMB, Britton H, Donahue DR, Boffi Q, Kim YS, Pritchard WF, Moonen C, Storm G, Lewis AL, Wood BJ. Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization. Sci Rep 2021;11:533. [PMID: 33436734 DOI: 10.1038/s41598-020-79900-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lei XF, Ke Y, Bao TH, Tang HR, Wu XS, Shi ZT, Lin J, Zhang ZX, Gu H, Wang L. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World J Clin Cases 2018; 6(5): 74-83 [PMID: 29774219 DOI: 10.12998/wjcc.v6.i5.74] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Kim S, Nowicki KW, Gross BA, Wagner WR. Injectable hydrogels for vascular embolization and cell delivery: The potential for advances in cerebral aneurysm treatment. Biomaterials 2021;277:121109. [PMID: 34530233 DOI: 10.1016/j.biomaterials.2021.121109] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]